KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Arbutus Biopharma (ABUS) Gross Margin: 2009-2025

Historic Gross Margin for Arbutus Biopharma (ABUS) over the last 16 years, with Sep 2025 value amounting to 100.00%.

  • Arbutus Biopharma's Gross Margin changed negligibly% to 100.00% in Q3 2025 from the same period last year, while for Sep 2025 it was 100.00%, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of 100.00% for FY2024, which is negligibly% changed negligibly from last year.
  • According to the latest figures from Q3 2025, Arbutus Biopharma's Gross Margin is 100.00%, which was down 0.00% from 100.00% recorded in Q2 2025.
  • Arbutus Biopharma's Gross Margin's 5-year high stood at 100.00% during Q1 2021, with a 5-year trough of 100.00% in Q1 2021.
  • Over the past 3 years, Arbutus Biopharma's median Gross Margin value was 100.00% (recorded in 2025), while the average stood at 100.00%.